We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · May 25, 2021

Psychotropic Medication and Outcomes in Alzheimer's Disease

Journal of the American Geriatrics Society


Additional Info

Journal of the American Geriatrics Society
Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD)
J Am Geriatr Soc 2021 Apr 01;69(4)955-963, ES Oh, PB Rosenberg, GB Rattinger, EA Stuart, CG Lyketsos, JS Leoutsakos

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading